Levomenthol

Levomenthol

SCHEMBL2960650

CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O.CC(O)CO.O=C(O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Levomenthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 4/20 0.68
TRPA1 known ✓ O75762 2/20 0.68
EPHX1 P07099 3/20 0.46
CYP19A1 P11511 2/20 0.39
ALDH1A1 P00352 1/20 0.38
KCNA5 P22460 1/20 0.36
TRPV1 Q8NER1 3/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menthol SCHEMBL583835 1.00 TRPM8 (0.68) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Menthol SCHEMBL2311281 0.93 TRPM8 (0.78) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Menthol SCHEMBL2634088 0.92 TRPM8 (0.66) TRPM8TRPA1EPHX1CYP19A1KCNA5
Menthol SCHEMBL583696 0.90 TRPM8 (0.72) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Levomenthol SCHEMBL2961481 0.90 TRPM8 (0.72) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Menthol SCHEMBL1664554 0.90 TRPM8 (0.84) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL15135035 0.87 TRPM8 (0.68) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Menthol SCHEMBL2671170 0.87 TRPM8 (0.72) TRPM8TRPA1EPHX1CYP19A1ALDH1A1
Menthol SCHEMBL320045 0.85 TRPM8 (0.75) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL1617429 0.85 TRPM8 (0.75) TRPM8TRPA1EPHX1CYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110558408-A Aerated herbal tea beverage and preparation method thereof 成都图径生物科技有限公司 2019-12-13 CN claimed
CN-114380693-B Methyl cyclopentenol ketogeraniol carbonate spice and synthetic method and application thereof 安徽中烟工业有限责任公司 2023-11-17 CN disclosed
CN-114516797-B Methyl cyclopentenolone menthol carbonate spice and synthetic method and application thereof 安徽中烟工业有限责任公司 2023-09-08 CN disclosed
CN-114516797-A Methyl cyclopentenolone menthol carbonate spice as well as synthesis method and application thereof 安徽中烟工业有限责任公司 2022-05-20 CN disclosed
CN-114380693-A Methyl cyclopentenolone geraniol carbonate spice and synthesis method and application thereof 安徽中烟工业有限责任公司 2022-04-22 CN disclosed
CN-111517958-B Perilla alcohol benzyl alcohol carbonate spice 北京工商大学 2022-01-25 CN disclosed
CN-111440071-B Perilla alcohol cinnamyl alcohol carbonate spice 北京工商大学 2022-01-25 CN disclosed
CN-111517958-A Perilla alcohol benzyl alcohol carbonate spice 北京工商大学 2020-08-11 CN disclosed
CN-111440071-A Perilla alcohol cinnamyl alcohol carbonate spice 北京工商大学 2020-07-24 CN disclosed
CN-110558408-A Aerated herbal tea beverage and preparation method thereof 成都图径生物科技有限公司 2019-12-13 CN disclosed
EP-2187871-B1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF SYMRISE AG (DE) 2016-04-13 EP disclosed
US-20100273887-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF SYMRISE GMBH & CO. KG (DE) 2010-10-28 US disclosed
EP-2187871-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF Symrise GmbH & Co. KG (DE) 2010-05-26 EP disclosed
WO-2009021558-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF SYMRISE GMBH & CO. KG (DE) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273887-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF NISCH, TAS2R40, TAS2R60 TRPM8 55/4885TRPA1 230/4885EPHX1 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.